Scientists track vaccine protection in cancer patients
NCT ID NCT06605625
Summary
This study aims to understand how well cancer patients' immune systems respond to common vaccines for flu, COVID-19, and shingles. Researchers will measure antibody levels in 250 adult cancer patients before and after they receive these vaccines. The goal is to learn how cancer and its treatments might affect vaccine protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIRAL VACCINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.